EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 22nd, 2003 • Ribapharm Inc • Pharmaceutical preparations • California
Contract Type FiledMay 22nd, 2003 Company Industry JurisdictionTHIS AGREEMENT (the “Agreement”) is entered into as of the 21st day of February, 2003, by and among RIBAPHARM INC. (the “Company”), and Kim D. Lamon, MD, PhD, an individual (the “Executive”) (hereinafter collectively referred to as “the parties”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 22nd, 2003 • Ribapharm Inc • Pharmaceutical preparations • California
Contract Type FiledMay 22nd, 2003 Company Industry JurisdictionTHIS AGREEMENT (the “Agreement”) is entered into as of the 21st day of February , 2003, by and among RIBAPHARM INC. (the “Company”) and WILLIAM M. COMER, JR., an individual (the “Executive”) (hereinafter collectively referred to as “the parties”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 22nd, 2003 • Ribapharm Inc • Pharmaceutical preparations • California
Contract Type FiledMay 22nd, 2003 Company Industry JurisdictionTHIS AGREEMENT (the “Agreement”) is entered into as of the 21st day of February , 2003, by and among RIBAPHARM INC. (the “Company”) and MEL D. DEUTSCH, an individual (the “Executive”)(hereinafter collectively referred to as “the parties”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 15th, 2003 • Ribapharm Inc • Pharmaceutical preparations • California
Contract Type FiledMay 15th, 2003 Company Industry JurisdictionTHIS AGREEMENT (the “Agreement”) is entered into as of the 21st day of February, 2003, by and among RIBAPHARM INC. (the “Company”), and Kim D. Lamon, MD, PhD, an individual (the “Executive”) (hereinafter collectively referred to as “the parties”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 15th, 2003 • Ribapharm Inc • Pharmaceutical preparations • California
Contract Type FiledMay 15th, 2003 Company Industry JurisdictionTHIS AGREEMENT (the “Agreement”) is entered into as of the 21st day of February , 2003, by and among RIBAPHARM INC. (the “Company”) and WILLIAM M. COMER, JR., an individual (the “Executive”) (hereinafter collectively referred to as “the parties”).